Conmed Corp
CNMD
View Detailed Chart
40.770USD
+0.600+1.49%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.26BMarket Cap
19.71P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.49%
5 Days
+2.05%
1 Month
-6.83%
6 Months
-22.11%
Year to Date
-40.43%
1 Year
-42.76%
View Detailed Chart
TradingKey Stock Score of Conmed Corp
Currency: USD Updated: 2025-12-26Key Insights
Conmed Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 39/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 50.20.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Conmed Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Hold
Current Rating
50.200
Target Price
+23.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Conmed Corp Highlights
StrengthsRisks
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 25.02% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 18.63%.
Fairly Valued
The company’s latest PE is 19.73, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 36.30M shares, increasing 0.00% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 18.13K shares of this stock.
Conmed Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Conmed Corp Info
CONMED Corporation is a medical technology company, which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Ticker SymbolCNMD
CompanyConmed Corp
CEOBeyer (Patrick J)
Websitehttps://www.conmed.com/
FAQs
What is the current price of Conmed Corp (CNMD)?
The current price of Conmed Corp (CNMD) is 40.770.
What is the symbol of Conmed Corp?
The ticker symbol of Conmed Corp is CNMD.
What is the 52-week high of Conmed Corp?
The 52-week high of Conmed Corp is 74.700.
What is the 52-week low of Conmed Corp?
The 52-week low of Conmed Corp is 38.320.
What is the market capitalization of Conmed Corp?
The market capitalization of Conmed Corp is 1.26B.
What is the net income of Conmed Corp?
The net income of Conmed Corp is 132.42M.
Is Conmed Corp (CNMD) currently rated as Buy, Hold, or Sell?
According to analysts, Conmed Corp (CNMD) has an overall rating of Hold, with a price target of 50.200.
What is the Earnings Per Share (EPS TTM) of Conmed Corp (CNMD)?
The Earnings Per Share (EPS TTM) of Conmed Corp (CNMD) is 2.068.
Related Instruments
+1.30%
+0.29%
+0.03%
+0.11%
-0.49%
-0.05%
-0.13%
-0.75%
+0.67%
+0.59%
+1.91%
+0.59%
+0.34%
+0.09%
+0.04%
+0.64%
+0.26%
+0.05%
+0.26%
+0.67%
